NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Net Income (TTM): -142.38M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -142.38M |
| September 30, 2023 | -151.14M |
| June 30, 2023 | -169.61M |
| March 31, 2023 | -177.86M |
| December 31, 2022 | -162.67M |
| September 30, 2022 | -153.46M |
| June 30, 2022 | -135.07M |
| March 31, 2022 | -125.24M |
| December 31, 2021 | -120.34M |
| September 30, 2021 | -121.09M |
| June 30, 2021 | -121.99M |
| Date | Value |
|---|---|
| March 31, 2021 | -110.92M |
| December 31, 2020 | -102.49M |
| September 30, 2020 | -90.44M |
| June 30, 2020 | -71.59M |
| March 31, 2020 | -53.64M |
| December 31, 2019 | -42.80M |
| September 30, 2019 | -12.69M |
| June 30, 2019 | -9.289M |
| March 31, 2019 | -4.82M |
| December 31, 2018 | -0.493M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-177.86M
Minimum
Mar 2023
-9.289M
Maximum
Jun 2019
-109.19M
Average
-121.09M
Median
Sep 2021
Net Income (TTM) Benchmarks
| Catalent Inc | -1.176B |
| AIM ImmunoTech Inc | -28.96M |
| Perspective Therapeutics Inc | -58.42M |
| Protalix BioTherapeutics Inc | 6.848M |
| Armata Pharmaceuticals Inc | -79.58M |